MEA Psychedelic Drugs Market - Industry Trends and Forecast to 2029
Middle East and Africa psychedelic drugs market is projected to register a substantial CAGR of 11.1% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.
Market Segmentation:
Middle East and Africa Psychedelic Drugs Market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)
Country (Saudi Arabia, UAE, Israel, Egypt, South Africa and Rest of Middle East and Africa). Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Middle East and AFRICA market are:
• Due to rise in healthcare expenditure and strategic initiatives taken by key market players
• Increasing Prevalence Of Depression And Mental Disorders
Market Players
The key market players for Middle East and Africa psychedelic drugs market are listed below:
• Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.)
• Hikma Pharmaceuticals PLC
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook